• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定卡塔尔国引发细支气管炎的因素。

Identifying agents triggering bronchiolitis in the State of Qatar.

作者信息

Hendaus Mohamed A, Alhammadi Ahmed H, Chandra Prem, Muneer Eshan, Khalifa Mohamed S

机构信息

Department of Pediatrics, Section of Academic General Pediatrics, Hamad General Corporation, Doha, Qatar.

Department of Pediatrics, Section of Academic General Pediatrics, Sidra Medicine, Doha, Qatar.

出版信息

Int J Gen Med. 2018 Apr 10;11:143-149. doi: 10.2147/IJGM.S154424. eCollection 2018.

DOI:10.2147/IJGM.S154424
PMID:29692622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5901157/
Abstract

BACKGROUND

Bronchiolitis is considered as the most frequent lower respiratory tract infection in infants and young children. This disorder is marked by acute inflammation, edema, damage of epithelial cells lining small airways, and augmentation of mucus production.

OBJECTIVE

The goal of the study was to identify agents triggering bronchiolitis in the State of Qatar.

MATERIALS AND METHODS

A cross-sectional retrospective study was performed at Hamad Medical Corporation, the only tertiary and academic medical center in the State of Qatar. The study included infants and young children aged 0-24 months who were admitted to our pediatric ward with diagnosis of acute bronchiolitis (2010-2012).

RESULTS

Eight hundred thirty-five infants and young children met the study inclusion criteria with mean age at diagnosis of 3.61±3.56 months. Respiratory virus real-time polymerase chain reaction was performed on 769 (92.0%) of the participants. Respiratory syncytial virus (RSV) was positive in 352 (45.7%) children admitted with clinical bronchiolitis. In addition, no viruses were identified in 142 (18.4%) of those admitted, and respiratory viruses other RSV were found in 275 (35.7%) of the children. Our investigations and observations show that there has been a steady and periodic seasonal variation in the RSV rate over the study period. A seasonal trend for the RSV (detected by respiratory virus real-time polymerase chain reaction) rate was evident, showing annual peaks in the months of October, November, December, and January, with a significant test for seasonality (test statistics []=3.15, =0.009).

CONCLUSION

In countries with desert hot weather, bronchiolitis might affect children throughout the year. Our results suggest that the combination of date regarding uninterrupted RSV seasonality can provide guidance for health care planning and application of RSV prevention scheme, such as extending the palivizumab immunoglobulin series.

摘要

背景

细支气管炎被认为是婴幼儿最常见的下呼吸道感染。这种疾病的特征是急性炎症、水肿、小气道内衬上皮细胞受损以及黏液分泌增加。

目的

本研究的目的是确定卡塔尔引发细支气管炎的因素。

材料与方法

在卡塔尔唯一的三级学术医疗中心哈马德医疗公司进行了一项横断面回顾性研究。该研究纳入了2010 - 2012年因急性细支气管炎诊断入住我们儿科病房的0 - 24个月的婴幼儿。

结果

835名婴幼儿符合研究纳入标准,诊断时的平均年龄为3.61±3.56个月。769名(92.0%)参与者进行了呼吸道病毒实时聚合酶链反应检测。352名(45.7%)临床诊断为细支气管炎的患儿呼吸道合胞病毒(RSV)呈阳性。此外,142名(18.4%)入院患儿未检测到病毒,275名(35.7%)患儿检测到除RSV外的其他呼吸道病毒。我们的调查和观察表明,在研究期间RSV感染率存在稳定的周期性季节性变化。RSV(通过呼吸道病毒实时聚合酶链反应检测)感染率呈现明显的季节性趋势,在10月、11月、12月和1月出现年度高峰,季节性检验具有显著性(检验统计量[] = 3.15,P = 0.009)。

结论

在沙漠炎热气候的国家,细支气管炎可能全年影响儿童。我们的结果表明,关于RSV季节性不间断的数据组合可为医疗保健规划和RSV预防方案的应用提供指导,如延长帕利珠单抗免疫球蛋白疗程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c814/5901157/de863310107b/ijgm-11-143Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c814/5901157/bfe50fd22187/ijgm-11-143Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c814/5901157/de863310107b/ijgm-11-143Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c814/5901157/bfe50fd22187/ijgm-11-143Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c814/5901157/de863310107b/ijgm-11-143Fig2.jpg

相似文献

1
Identifying agents triggering bronchiolitis in the State of Qatar.确定卡塔尔国引发细支气管炎的因素。
Int J Gen Med. 2018 Apr 10;11:143-149. doi: 10.2147/IJGM.S154424. eCollection 2018.
2
The epidemiology of respiratory syncytial virus: A retrospective review from Steve Biko Academic Hospital 2013 - 2016.呼吸道合胞病毒的流行病学:来自史蒂夫·比科学术医院2013 - 2016年的回顾性研究
Afr J Thorac Crit Care Med. 2018 Apr 3;24(1). doi: 10.7196/AJTCCM.2017.v24i1.163. eCollection 2018.
3
Clinical characteristics of respiratory syncytial virus infection in hospitalized healthy infants and young children in Qatar.卡塔尔住院健康婴幼儿呼吸道合胞病毒感染的临床特征
J Trop Pediatr. 2001 Dec;47(6):363-6. doi: 10.1093/tropej/47.6.363.
4
Hospitalization for Respiratory Syncytial Virus Bronchiolitis in the Palivizumab Prophylaxis Era: Need for Reconsideration of Preventive Timing and Eligibility.帕利珠单抗预防时代呼吸道合胞病毒细支气管炎的住院治疗:需要重新考虑预防时机和适用标准。
Isr Med Assoc J. 2019 Feb;21(2):110-115.
5
Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?呼吸道合胞病毒感染的预防(帕利珠单抗)——是否值得?
Ir Med J. 2000 Dec;93(9):284.
6
Risk factors for respiratory syncytial virus bronchiolitis hospitalizations in children with chronic diseases.慢性疾病儿童毛细支气管炎住院的呼吸道合胞病毒危险因素。
Pediatr Pulmonol. 2021 Jul;56(7):2204-2211. doi: 10.1002/ppul.25435. Epub 2021 May 7.
7
Respiratory syncytial virus: can we still believe that after pandemic bronchiolitis is not a critical issue for public health?呼吸道合胞病毒:大流行后毛细支气管炎不再是公共卫生的重大问题,我们还能相信这一点吗?
Eur J Pediatr. 2023 Dec;182(12):5303-5313. doi: 10.1007/s00431-023-05201-y. Epub 2023 Sep 20.
8
Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years.2 岁以下儿童因呼吸道合胞病毒住院的发生率和危险因素。
Epidemiol Infect. 2022 Feb 2;150:e45. doi: 10.1017/S0950268822000152.
9
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.帕利珠单抗预防高危婴儿和幼儿呼吸道合胞病毒(RSV)毛细支气管炎的免疫预防作用:亚组分析的系统评价和额外的经济建模。
Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050.
10
Assessing the burden of bronchiolitis and lower respiratory tract infections in children ≤24 months of age in Italy, 2012-2019.评估2012年至2019年意大利24个月及以下儿童的细支气管炎和下呼吸道感染负担。
Front Pediatr. 2023 May 5;11:1143735. doi: 10.3389/fped.2023.1143735. eCollection 2023.

引用本文的文献

1
Impact of COVID‑19 pandemic restrictions and subsequent relaxation on the prevalence of respiratory virus hospitalizations in children.COVID-19 大流行限制措施及其后续放宽对儿童呼吸道病毒住院患病率的影响。
BMC Pediatr. 2024 Feb 2;24(1):91. doi: 10.1186/s12887-024-04566-9.
2
Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial.雾化吸入3%高渗盐水与异丙托溴铵治疗小儿毛细支气管炎的比较:一项随机对照试验
Ann Med Surg (Lond). 2023 Sep 5;85(11):5484-5490. doi: 10.1097/MS9.0000000000001174. eCollection 2023 Nov.
3
Systematic review and meta-analysis of the prevalence of common respiratory viruses in children < 2 years with bronchiolitis in the pre-COVID-19 pandemic era.

本文引用的文献

1
Natural history and epidemiology of respiratory syncytial virus infection in the Middle East: Hospital surveillance for children under age two in Jordan.中东地区呼吸道合胞病毒感染的自然史和流行病学:约旦对两岁以下儿童的医院监测。
Vaccine. 2015 Nov 25;33(47):6479-87. doi: 10.1016/j.vaccine.2015.08.048. Epub 2015 Aug 24.
2
Eighteen Years of Respiratory Syncytial Virus Surveillance: Changes in Seasonality and Hospitalization Rates in Southwestern Alaska Native Children.18年呼吸道合胞病毒监测:阿拉斯加西南部原住民儿童季节性变化及住院率情况
Pediatr Infect Dis J. 2015 Sep;34(9):945-50. doi: 10.1097/INF.0000000000000772.
3
在 COVID-19 大流行之前,对儿童<2 岁毛细支气管炎常见呼吸道病毒流行率的系统评价和荟萃分析。
PLoS One. 2020 Nov 12;15(11):e0242302. doi: 10.1371/journal.pone.0242302. eCollection 2020.
4
Systematic Review of the Respiratory Syncytial Virus (RSV) Prevalence, Genotype Distribution, and Seasonality in Children from the Middle East and North Africa (MENA) Region.中东和北非(MENA)地区儿童呼吸道合胞病毒(RSV)流行率、基因型分布及季节性的系统评价
Microorganisms. 2020 May 11;8(5):713. doi: 10.3390/microorganisms8050713.
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.
临床实践指南:细支气管炎的诊断、管理及预防
Pediatrics. 2014 Nov;134(5):e1474-502. doi: 10.1542/peds.2014-2742.
4
Maternal immunization.母体免疫
Clin Infect Dis. 2014 Aug 15;59(4):560-8. doi: 10.1093/cid/ciu327. Epub 2014 May 5.
5
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.基于结构的融合糖蛋白疫苗设计用于呼吸道合胞病毒。
Science. 2013 Nov 1;342(6158):592-8. doi: 10.1126/science.1243283.
6
Viral etiology of acute respiratory infections in hospitalized and outpatient children in Buenos Aires, Argentina.阿根廷布宜诺斯艾利斯住院和门诊儿童急性呼吸道感染的病毒病因。
Pediatr Infect Dis J. 2013 Mar;32(3):e105-10. doi: 10.1097/INF.0b013e31827cd06f.
7
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers.融合后呼吸道合胞病毒融合 F 糖蛋白(RSV F)免疫接种的结构基础,可引发高中和抗体滴度。
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9619-24. doi: 10.1073/pnas.1106536108. Epub 2011 May 17.
8
Respiratory syncytial virus infections in Central Australia.澳大利亚中部的呼吸道合胞病毒感染
J Paediatr Child Health. 2010 Jan;46(1-2):35-9. doi: 10.1111/j.1440-1754.2009.01614.x. Epub 2009 Nov 23.
9
Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention.美国一岁内因呼吸道合胞病毒下呼吸道感染而需要医疗护理的早产婴儿的总医疗费用。
Curr Med Res Opin. 2009 Nov;25(11):2795-804. doi: 10.1185/03007990903290894.
10
The burden of respiratory syncytial virus infection in young children.幼儿呼吸道合胞病毒感染的负担
N Engl J Med. 2009 Feb 5;360(6):588-98. doi: 10.1056/NEJMoa0804877.